<DOC>
	<DOCNO>NCT01160315</DOCNO>
	<brief_summary>Chemotherapy drug like alkylating agent frequently use various combined regimen treat neoplastic benign disease . These drug definitely associate premature ovarian failure ( POF ) , result important decrease long-term quality life increase morbidity . A recent study show patient treat alkylating agent 4.52 fold high risk lose ovarian function compare treated agent . The rate POF treatment range 40 80 % , accord age patient total dos administer . Young woman experience POF face prospect infertility consider year hormonal replacement therapy . The possibility minimize gonadal damage administer protective therapy chemotherapy represent attractive option patient . The aim study evaluate protective effect ovarian function gonadotropin-releasing hormone agonist ( GnRha ) administer concomitantly alkylating agent . Preliminary data literature animal ( rat monkey ) promising . Data human , however , highly controversial .</brief_summary>
	<brief_title>Efficiency Gonadotropin-releasing Hormone ( GnRH ) Agonist Preventing Chemotherapy Induced Ovarian Failure</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Women 18 45 year old lymphoma . Menarche &gt; 2year Subject treat chemotherapyinduced ovarian failure include alkylant agent ( except less 8 ABVD ) Presence ovary ( ovarian biopsy hemiovariectomy cryopreservation treatment accept ) . Ability give write informed consent Hormonalsensible malignancy Chemotherapy radiotherapy inclusion study Pelvic irradiation include ovary TBI Pregnancy Patient weight 110 kg Anamnesis thromboembolic process Severe hepatic renal insufficiency Systolic blood pressure &gt; 15mmHg diastolic blood pressure &gt; 90mmHg Contraindication IM injection Relevant ovarian abnormality ( Functional follicular cyst tolerate ) Anamnesis premature ovarian failure irregular cycle ( repeat amenorrhoea &gt; 2 month ) DubinJohnson Rotor Syndrome</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>ovarian failure , chemotherapy , lymphoma , GnRH agonist</keyword>
</DOC>